| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/27/2013 | CN102947323A Novel caspase-14 activator peptides and compositions comprising said peptides |
| 02/27/2013 | CN102946898A Agent for reducing acetaldehyde in oral cavity |
| 02/27/2013 | CN102946897A Treatment of vascular complications of diabetes |
| 02/27/2013 | CN102946896A Sox9 inhibitors |
| 02/27/2013 | CN102946895A The use of des-aspartate-angiotensin i in inflammation-related pathologies and diseases |
| 02/27/2013 | CN102946892A A composition for use in the therapy of lactose intolerance or conditions arising from lactase deficiency |
| 02/27/2013 | CN102946888A Compositions containing purine and pyrimidine nucleosides, peptides, and manganese and their uses |
| 02/27/2013 | CN102946875A 组合疗法 Combination therapy |
| 02/27/2013 | CN102946863A Long-term storage of non-glycosylated recombinant human G-CSF |
| 02/27/2013 | CN102943067A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 02/27/2013 | CN102942626A Glucagon-like peptide-2 analogue, its preparation method and application |
| 02/27/2013 | CN102942624A Galectin-3 binding protein, preparation and application thereof |
| 02/27/2013 | CN102942618A Telomeric protein polypeptide fragment with tumor cell killing activity and application thereof |
| 02/27/2013 | CN102942617A Streptococcus suis quorum sensing system blocking peptide and application of streptococcus suis quorum sensing system blocking peptide |
| 02/27/2013 | CN102941688A Method for manufacturing health care toilet paper |
| 02/27/2013 | CN102940886A Biological barrier penetrating agent and preparation method thereof |
| 02/27/2013 | CN102940882A Medicine for treating respiratory diseases |
| 02/27/2013 | CN102940881A Ointment for treating skin scalds |
| 02/27/2013 | CN102940880A Growth factor complex |
| 02/27/2013 | CN102940879A Stabilized pharmaceutical peptide compositions |
| 02/27/2013 | CN102940878A Spinal nucleus pulposus implant |
| 02/27/2013 | CN102940877A Application of polypeptide DM29 in preparing drugs for increasing natural immunity of goats |
| 02/27/2013 | CN102940876A Application of polypeptide GH27 in preparation of medicament for preventing and treating goat diarrhea |
| 02/27/2013 | CN102940875A Paa protein, antibody prepared from the same, and application thereof |
| 02/27/2013 | CN102940874A Application of small molecular polypeptide CW14 in preparation of goat antibacterial medicament |
| 02/27/2013 | CN102940622A 腹膜透析液 Peritoneal dialysate |
| 02/27/2013 | CN102940609A Octreotide sustained-release microspheres with high encapsulation rate and preparation method thereof |
| 02/27/2013 | CN102940602A Essence powder for body care |
| 02/27/2013 | CN102526745B Slow-release method for controlling medicine-carrying molecules of lyotopic liquid crystal by using micro electric field |
| 02/27/2013 | CN102429891B Method for preparing low-molecular-weight sheep bone collagen polypeptide calcium chelate microcapsules |
| 02/27/2013 | CN102335417B Health-care product for restoring physical strength in later period of cold |
| 02/27/2013 | CN102228680B Thymosin phospholipids/bile salt compound micelle and preparation method and preparation thereof |
| 02/27/2013 | CN102153619B Small molecular weight glycopeptide extracted from stiff silkworm as well as extraction separation method and application thereof |
| 02/27/2013 | CN102145164B IAPP (Islet Amyloid Polypeptide) analog injection with better stability |
| 02/27/2013 | CN102145162B Injection of medicine for treating premature delivery |
| 02/27/2013 | CN102085356B Composition for increasing bone mineral density and preparation method thereof |
| 02/27/2013 | CN101959532B Pharmaceutical composition for transnasal administration |
| 02/27/2013 | CN101928742B Whey protein active peptide with antioxidant activity and preparation method thereof |
| 02/27/2013 | CN101863962B Polypeptide for inhibiting enzyme digestion of beta secretase and application thereof |
| 02/27/2013 | CN101785853B Mesenchymal stem cell biological winkle removing agent and preparation method thereof |
| 02/27/2013 | CN101757631B Composition of biocompatible microparticles of alginic acid for the controlled release of active ingredients by intravenous administration |
| 02/27/2013 | CN101355959B Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| 02/26/2013 | US8383919 Highly fluorescent peptide-metallic nanoclusters as bio-probes and methods of synthesis thereof |
| 02/26/2013 | US8383804 Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof |
| 02/26/2013 | US8383790 Modified surface antigen |
| 02/26/2013 | US8383788 For therapy of cancer or tumorous growth |
| 02/26/2013 | US8383787 Use of lipid conjugates in the treatment of diseases |
| 02/26/2013 | US8383777 13-transmembrane protein expressed in prostate cancer |
| 02/26/2013 | US8383776 Purification of factor XIII polypeptides from biological materials |
| 02/26/2013 | US8383775 Cytokine zalpha11 ligand |
| 02/26/2013 | US8383772 Ang-(1-7) receptor agonist |
| 02/26/2013 | US8383771 Altered peptide ligand derived from HSP60 and pharmaceutical compositions |
| 02/26/2013 | US8383770 Boc and Fmoc solid phase peptide synthesis |
| 02/26/2013 | US8383769 Peptides for inhibiting chemokine binding to chemokine receptors |
| 02/26/2013 | US8383767 Immunogenic protein carrier containing an antigen presenting cell binding domain and a cysteine-rich domain |
| 02/26/2013 | US8383653 SIR2 regulation |
| 02/26/2013 | US8383648 Applying such as 1-oxyl-4-(3'-ethoxy-2',2'-dimethyl)propanecarbonyloxy-2,2,6,6-tetramethylpiperidine to eye surface; halting growth, preventing surgery |
| 02/26/2013 | US8383599 Methods and compositions for RNA interference |
| 02/26/2013 | US8383595 Peptide derivative and composition for promoting tear secretion comprising the same |
| 02/26/2013 | US8383594 Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals |
| 02/26/2013 | US8383593 αvβ6 peptide ligands and their uses |
| 02/26/2013 | US8383591 Peptides for treating cancer |
| 02/26/2013 | US8383590 Peptide vaccines for cancers expressing tumor-associated antigens |
| 02/26/2013 | US8383589 Aegyptin and uses thereof |
| 02/26/2013 | US8383588 Fibrosis inhibitor for implanted organ |
| 02/26/2013 | US8383587 Prevention of allergy at weaning |
| 02/26/2013 | US8383586 Compositions and methods for soft tissue repair |
| 02/26/2013 | US8383585 Biomarkers for cardiodiabetes |
| 02/26/2013 | US8383584 HCV inhibiting macrocyclic phenylcarbamates |
| 02/26/2013 | US8383583 Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors |
| 02/26/2013 | US8383582 Inhibitor against forming biofilm comprising κ-casein macropeptide |
| 02/26/2013 | US8383581 Short-chain peptides as parathyroid hormone (PTH) receptor agonist |
| 02/26/2013 | US8383580 Methods of administering lipocalins to treat metabolic disorders and cardiovascular diseases |
| 02/26/2013 | US8383579 Method for customized dispensing of variable dose drug combination products for individualizing of therapies |
| 02/26/2013 | US8383578 Peptides, derivatives and analogs thereof, and methods of using same |
| 02/26/2013 | US8383577 Octreotide implant having a release agent |
| 02/26/2013 | US8383576 LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized |
| 02/26/2013 | US8383394 System and method for electroporating a sample |
| 02/26/2013 | US8383388 for oral administration; exhibit increased protein stability; exhibit increased stability in the bloodstream, following oral administration, and/or under storage conditions |
| 02/26/2013 | US8383386 Compositions and methods for modulating hemostasis |
| 02/26/2013 | US8383365 Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivatives |
| 02/26/2013 | US8383158 Methods and compositions to treat myocardial conditions |
| 02/26/2013 | US8383153 Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same |
| 02/26/2013 | US8383147 Reinforced absorbable synthetic matrix for hemostatic applications |
| 02/26/2013 | US8383141 Dry hemostatic compositions and methods for their preparation |
| 02/26/2013 | US8383130 Partial peptide of lacritin |
| 02/26/2013 | US8383129 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 02/26/2013 | US8383126 Bacterial pheromones and uses thereof |
| 02/26/2013 | US8383125 Antimicrobial protein |
| 02/26/2013 | US8383120 Concomitant treatment of rheumatoid arthritis with anti-TNF-alpha antibodies and methotrexate |
| 02/26/2013 | US8383119 Biological substance nesfatin and its related substances and uses thereof |
| 02/26/2013 | US8383117 CD44E tumor specific antibody |
| 02/26/2013 | US8383110 Modulators of Candida hyphal morphogenesis and uses thereof |
| 02/26/2013 | US8383105 Pharmacological vitreolysis |
| 02/26/2013 | US8383104 Thrombin-free biological adhesive and use thereof as a medicament |
| 02/26/2013 | US8383103 Treating cholecystitis with separate mixtures comprising extracellular matrix digesting enzyme and botulinum toxin |
| 02/26/2013 | US8383102 Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens |
| 02/26/2013 | US8383101 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 02/26/2013 | US8383100 Method to treat and prevent skin diseases with Porifera-based therapeutic compositions treating and preventing skin diseases |
| 02/26/2013 | US8383094 Hepatitis C virus inhibitors |